De Groot, Anne S.
Mattei, Aimee
Gabriel, Benjamin
Calderini, Jennifer
Roberts, Brian J.
Lelias, Sandra
McAllister, Mitchell
Boyle, Christine
Martin, William
Richard, Guilhem
Article History
Received: 2 December 2024
Accepted: 25 February 2025
First Online: 24 March 2025
Declarations
:
: ADG and WDM are senior officers and majority shareholders of EpiVax, Inc, a privately owned immunoinformatics and vaccine design company. ADG, BG, AM, WDM, JC, BR, SL, CB, GR, and MM are employees of EpiVax, Inc. Due to this relationship with EpiVax, these authors acknowledge that there is a potential conflict of interest inherent in the publication of this manuscript, and attest that the work contained in this research report is free of any bias that might be associated with the commercial goals of the company.